Abstract
BackgroundSpondyloarthritis (SpA) comprises a heterogeneous group of diseases sharing several clinical, biochemical and radiological features. Biomarkers for SpA are scarce and their validation in real practice is essential in predicting...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have